Intellectual Property India Publishes Patent Application for 'Substituted Phenylbenzenesulfonamide Derivatives And Uses Thereof' Filed by Nine Square Therapeutics Corporation

MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517050436 A) filed by Nine Square Therapeutics Corporation, San Francisco, on May 26, for 'substituted phenylbenzenesulfonamide derivatives and uses thereof.'

Inventor(s) include Rosen, Mark D.; Cong, Qiang; Kalyanaraman, Chakrapani; and Dow, Robert Lee.

The application for the patent was published on June 13, under issue no. 24/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are substituted phenylbenzenesulfonamide compounds and compositions thereof for modulating TRPML1. In some embodiments, the compounds and compositions are provided for treatment of neurodegenerative diseases."

The patent application was internationally filed on Oct. 27, 2023, under International application No.PCT/US2023/078090.

Disclaimer: Curated by HT Syndication.